Global Embolic Protection Devices Market was valued US$ 403.6 Mn in 2019 and is expected to reach US$ 754.2 Mn by 2026, at a CAGR of 8.13 % during a forecast period.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
The embolic protection devices are used to capture & remove the number of difficulties during percutaneous cardiac procedures such as debris i.e. damaged cells or tissue being released into the bloodstream & causing blockages in smaller vessels.
The major driving factors of the global embolic protection devices are rising incidence of cardiovascular & neurovascular diseases, growing funding & investments, a launc
The major driving factors of the global embolic protection devices are rising incidence of cardiovascular & neurovascular diseases, growing funding & investments, a launch of technologically advanced, and increasing demand of minimally invasive heart procedures such as carotid artery stenting & transcatheter aortic valve replacement (TAVR). The growth in the number of transcatheter aortic valve replacement procedures is expanding the market owing to the rising elderly population, growing fat population, increasing occurrence of aortic stenosis in heart patients. However, product failure and recalls are limiting market growth. Strict regulatory situation & unfavorable government policies, and lack of skilled professionals are also hindering the market growth.
Distal filter devices segment is the largest segment and accounted for approximately 80% of the total market share owing to the high demand for these devices. This device allows continuing circulating of blood through the pores of the filter. Distal filters also allow for different media injection during the procedure for lesion & arterial visualization.
Distal occlusion devices use a balloon catheter to temporarily block the flow of blood in a vessel while the intervention is performed. A catheter is a thin tube prepared from medical grade materials & serving a broad range of functions and inserted in the body to treat diseases as well as perform a surgical procedure. The limiting factor of distal occlusion is that these devices require fast action by the interventional team to complete a procedure in four to six minutes so blood flow can be restored.
Neurovascular diseases are expected for the largest share owing to the growing cases of neurological disorders. The constant development of catheters & guidewires to prevent clots from forming in arteries are increasing the market growth. Preference of minimally invasive surgeries, improvement of new devices, and favorable reimbursement policies are also the boosting the growth of this segment.
North America is leading the embolic protection devices market, followed by Europe and Asia Pacific region, owing to the growing aging population, which ultimately leads to the increasing patient population, a rising occurrence of cardiovascular & neurovascular diseases. Increasing adoption of minimally invasive techniques, growing availability of funding to develop novel products, and the strong presence of device manufacturers in the country also enhance the growth of embolic protection devices in the North American region.
Some of the leading players in the global embolic protection devices market are Abbott Laboratories, Claret Medical Inc, Boston Scientific Corporation, Contego Medical LLC, Medtronic Inc, L. Gore & Associates Inc, Ltd., Cardinal Health Inc, AngioSlide, Allium Medical Solutions Ltd. and Silk Road Medical Inc.
Scope of Global Embolic Protection Devices Market:
Global Embolic Protection Devices Market, by Type:
• Distal filter devices
• Distal occlusion devices
• Proximal occlusion devices
Global Embolic Protection Devices Market, by Material:
Global Embolic Protection Devices Market, by Application:
• Cardiovascular diseases
• Neurovascular diseases
• Peripheral vascular diseases
Global Embolic Protection Devices Market, by End-User:
• Ambulatory Surgical Centers
Global Embolic Protection Devices Market, by Region:
• North America
• South America
• Middle East & Africa
Key Player Operating In the Global Embolic Protection Devices Market:
• Abbott Laboratories
• Claret Medical Inc.
• Boston Scientific Corporation
• Contego Medical LLC
• Medtronic Inc
• L. Gore & Associates Inc, Ltd.
• Cardinal Health Inc
• Allium Medical Solutions Ltd.
• Silk Road Medical Inc.
For more information of visit:https://www.maximizemarketresearch.com/market-report/global-embolic-protection-devices-market/22378/
This report submitted by Maximize market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Name: Lumawant Godage
Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.
Email: [email protected]
: Omkar Heights,